A detailed history of Centerpoint Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 4,000 shares of BSX stock, worth $334,480. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$334,480
Previous $308,000 8.77%
% of portfolio
0.12%
Previous 0.11%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$48.64 - $57.81 $875 - $1,040
-18 Reduced 0.45%
4,000 $231,000
Q1 2023

May 03, 2023

BUY
$45.09 - $50.03 $811 - $900
18 Added 0.45%
4,018 $201,000
Q4 2022

Jan 24, 2023

SELL
$39.56 - $47.22 $3,718 - $4,438
-94 Reduced 2.3%
4,000 $185,000
Q2 2021

Jul 26, 2021

BUY
$38.58 - $44.24 $154,320 - $176,960
4,000 Added 4255.32%
4,094 $175,000
Q2 2018

Aug 13, 2018

BUY
$26.84 - $34.32 $1,637 - $2,093
61 Added 184.85%
94 $3,000
Q1 2018

May 09, 2018

BUY
$25.2 - $28.54 $831 - $941
33 New
33 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.